ROFI, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 1560
EU - Europa 622
AS - Asia 179
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
SA - Sud America 3
Totale 2439
Nazione #
US - Stati Uniti d'America 1525
IT - Italia 243
SE - Svezia 127
CN - Cina 119
BG - Bulgaria 80
CI - Costa d'Avorio 49
DE - Germania 46
AT - Austria 39
GB - Regno Unito 39
CA - Canada 34
VN - Vietnam 32
FR - Francia 13
NG - Nigeria 9
NL - Olanda 9
EU - Europa 8
AU - Australia 7
IN - India 7
BE - Belgio 6
ES - Italia 6
JP - Giappone 6
KR - Corea 6
BR - Brasile 3
CH - Svizzera 2
FI - Finlandia 2
LK - Sri Lanka 2
PL - Polonia 2
RO - Romania 2
RU - Federazione Russa 2
TR - Turchia 2
TW - Taiwan 2
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
UA - Ucraina 1
Totale 2439
Città #
Fairfield 237
Woodbridge 221
Houston 164
Chandler 140
Seattle 108
Ashburn 88
Cambridge 86
Sofia 80
Serra 78
Wilmington 77
Ann Arbor 72
Pisa 50
Abidjan 49
Princeton 43
Vienna 38
Lawrence 32
Beijing 31
Ottawa 30
London 27
Frankfurt am Main 25
Medford 24
Dearborn 18
Nanjing 17
Des Moines 16
Dong Ket 15
Boulder 14
Chiesina Uzzanese 11
San Diego 11
Rome 10
Lagos 9
Redwood City 9
Hefei 8
Kunming 7
Bremen 6
Iowa City 6
San Francisco 6
Brussels 5
Changsha 5
Florence 4
Milan 4
Phoenix 4
Shanghai 4
Chengdu 3
Guangzhou 3
Hebei 3
Jiaxing 3
Lancaster 3
Nanchang 3
Norwalk 3
Pistoia 3
Redmond 3
Shenyang 3
Baotou 2
Kolkata 2
Montréal 2
Nutley 2
Perth 2
Polska 2
Prato 2
Santiago De Compostela 2
Savona 2
Seoul 2
Tianjin 2
Zhengzhou 2
Amsterdam 1
Andover 1
Azor 1
Bari 1
Berlin 1
Bologna 1
Bucharest 1
Cagliari 1
Caserta 1
Castelnuovo Rangone 1
Colombo 1
Columbus 1
Daejeon 1
Dallas 1
Daly City 1
Diemen 1
Diyarbakir 1
Formigine 1
Freitas 1
Fuzhou 1
Groningen 1
Göttingen 1
Hanover 1
Indiana 1
Leawood 1
Livorno 1
Madrid 1
Markham 1
Marseille 1
Minervino Murge 1
Minneapolis 1
Monmouth Junction 1
Napoli 1
Newton-le-willows 1
Nocera Inferiore 1
Notre Dame 1
Totale 1979
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 213
null 142
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer 115
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 105
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 97
Clinical pharmacology of intravitreal anti-VEGF drugs 96
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 95
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 91
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 90
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 89
Pharmacokinetic Markers of 5-Fluorouracil Toxicity in Clinical Trials and Real World 87
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 84
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment 84
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 84
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 78
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 78
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 74
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 70
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 69
Primary resistance to osimertinib due to SCLC transformation: Issue of T790M determination on liquid re-biopsy 67
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 63
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial 62
null 60
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer 58
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 57
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 57
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 55
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 50
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 44
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 42
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 39
Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer 36
Should CYP2D6 be genotyped when treating with tamoxifen? 18
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 3
Totale 2552
Categoria #
all - tutte 4624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018161 0000 00 00 76133240
2018/2019316 176127 317 474 8357468
2019/2020681 61717348 6676 7670 64333310
2020/2021255 1618717 1112 3214 45153038
2021/2022335 51587 6566 188 20121893
2022/2023536 63894633 5261 1149 132000
Totale 2552